Published in J Virol on September 01, 2002
Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1. EMBO J (2008) 1.66
Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc Natl Acad Sci U S A (2006) 1.31
Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway. Oncogene (2008) 1.18
High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression. J Virol (2011) 1.16
In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis. Cancer Res (2010) 1.10
The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication. J Virol (2010) 0.98
Human papillomavirus episome stability is reduced by aphidicolin and controlled by DNA damage response pathways. J Virol (2013) 0.96
Human papillomaviruses and the interferon response. J Interferon Cytokine Res (2009) 0.91
Inactivation of p53 rescues the maintenance of high risk HPV DNA genomes deficient in expression of E6. PLoS Pathog (2013) 0.90
Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines. Int J Cancer (2014) 0.88
Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7. J Virol (2004) 0.87
APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon beta interferon stimulation. J Virol (2013) 0.85
High-risk human papillomavirus targets crossroads in immune signaling. Viruses (2015) 0.79
Recent Insights into the Control of Human Papillomavirus (HPV) Genome Stability, Loss, and Degradation. J Clin Med (2015) 0.79
Activation of NF-κB by human papillomavirus 16 E1 limits E1-dependent viral replication through degradation of E1. J Virol (2015) 0.79
Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes. J Virol (2011) 0.78
Evasion of Host Immune Defenses by Human Papillomavirus. Virus Res (2016) 0.77
Interferon Kappa Inhibits Human Papillomavirus 31 Transcription by Inducing Sp100 Proteins. J Virol (2015) 0.77
The human papillomavirus E7 oncoprotein as a regulator of transcription. Virus Res (2016) 0.76
Host cell restriction factors that limit transcription and replication of human papillomavirus. Virus Res (2016) 0.75
Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism. J Virol (2017) 0.75
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
How cells respond to interferons. Annu Rev Biochem (1998) 24.27
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell (1990) 20.60
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54
Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell (1975) 15.93
Cellular responses to interferon-gamma. Annu Rev Immunol (1997) 13.23
Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science (1990) 12.88
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell (1993) 12.41
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J (1989) 7.69
Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product. Cell (1985) 7.56
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol (2000) 7.00
Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol (1987) 6.65
A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J (1991) 5.39
Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science (1990) 4.92
Activation of BPV-1 replication in vitro by the transcription factor E2. Nature (1991) 4.51
Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science (1992) 4.49
The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol (1991) 4.18
The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell (1982) 4.17
The papillomavirus E2 regulatory proteins. J Biol Chem (1991) 3.27
Human papillomaviruses. Annu Rev Microbiol (1994) 2.88
Host defense, viruses and apoptosis. Cell Death Differ (2001) 2.84
Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev (1995) 2.76
Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol (1997) 2.71
In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. Proc Natl Acad Sci U S A (1996) 2.54
Human pathogenic papillomavirus types: an update. Curr Top Microbiol Immunol (1994) 2.50
Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. J Virol (2000) 2.44
Regulation of MHC class II genes: lessons from a disease. Annu Rev Immunol (1996) 2.42
Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J Virol (1997) 2.21
The effect of interferon on SV-40 T antigen production in SV-40-transformed cells. Virology (1967) 2.13
Genital human papillomavirus infection. Proc Natl Acad Sci U S A (1994) 2.12
Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature (1991) 2.09
Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res (1998) 2.04
Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc Natl Acad Sci U S A (1999) 2.00
The biology of human papillomaviruses: from warts to cancer. Infect Agents Dis (1993) 1.78
Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines. Clin Cancer Res (2001) 1.73
The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene (1992) 1.68
Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein. Proc Natl Acad Sci U S A (1994) 1.62
The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b. Virology (1994) 1.61
In vitro systems for the study and propagation of human papillomaviruses. Curr Top Microbiol Immunol (1994) 1.61
Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. J Virol (1997) 1.59
Cell-free replication of the human papillomavirus DNA with homologous viral E1 and E2 proteins and human cell extracts. J Biol Chem (1994) 1.56
Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. J Gen Virol (1987) 1.48
pac gene as efficient dominant marker and reporter gene in mammalian cells. Methods Enzymol (1992) 1.48
The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J Virol (1995) 1.48
The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha. Virology (1999) 1.46
Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells. Proc Natl Acad Sci U S A (1982) 1.46
The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene (1999) 1.44
Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions. J Virol (1998) 1.40
Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. EMBO J (1994) 1.37
The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J Biol Chem (2000) 1.33
Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Investig Med (1997) 1.26
Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells. Cancer Res (1982) 1.25
Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E. J Virol (1998) 1.24
E1 protein of human papillomavirus type 1a is sufficient for initiation of viral DNA replication. Proc Natl Acad Sci U S A (1994) 1.23
Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins. Oncogene (1999) 1.13
Tyrosine-phosphorylated plakoglobin is associated with desmogleins but not desmoplakin after epidermal growth factor receptor activation. J Biol Chem (2001) 1.07
Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins. Cancer Res (1998) 1.03
Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. Mol Cell Biol (1996) 1.02
Mechanism of interferon beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines. J Natl Cancer Inst (1995) 0.92
Induction of multiple programmed cell death pathways by IFN-beta in human non-small-cell lung cancer cell lines. Exp Cell Res (1999) 0.88
Orientation of a novel DNA binding site affects human papillomavirus-mediated transcription and replication. J Virol (2001) 0.83
Interferon-beta induces S phase accumulation selectively in human transformed cells. J Interferon Cytokine Res (1997) 0.83
No effect of intralesional injection of interferon on moderate cervical intraepithelial neoplasia. Br J Obstet Gynaecol (1990) 0.82
Selectivity of interferon action in simian virus 40-transformed cells superinfected with simian virus 40. J Virol (1985) 0.79
Human papillomavirus DNA as a possible index of invasiveness in female genital tract carcinomas. Eur J Cancer (1991) 0.79
Human fibroblast interferon in cervical and vulvar intraepithelial neoplasia associated with viral cytopathic effects. A pilot study. J Reprod Med (1985) 0.78
Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov (2007) 6.33
Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer (2010) 4.99
Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol (2002) 4.31
Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol (2004) 3.54
Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev (2004) 3.52
2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature (2010) 3.49
Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology (2006) 3.00
Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J Virol (2003) 2.69
Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J (2010) 2.36
The ISG56/IFIT1 gene family. J Interferon Cytokine Res (2010) 2.32
A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology (2007) 2.30
Novel functions of proteins encoded by viral stress-inducible genes. Pharmacol Ther (2004) 2.25
Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol (2006) 2.22
Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog (2009) 2.21
IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA. Proc Natl Acad Sci U S A (2002) 2.20
Crystal structure of the 2'-specific and double-stranded RNA-activated interferon-induced antiviral protein 2'-5'-oligoadenylate synthetase. Mol Cell (2003) 2.16
Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J Biol Chem (2006) 2.15
Interferons and viral infections. Biofactors (2009) 1.99
Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol (2010) 1.96
IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence. J Virol (2008) 1.89
Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog (2012) 1.84
Intermediate filament-membrane attachments function synergistically with actin-dependent contacts to regulate intercellular adhesive strength. J Cell Biol (2002) 1.83
Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.Met-tRNAi. J Biol Chem (2003) 1.74
p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs. Proc Natl Acad Sci U S A (2012) 1.71
Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1. EMBO J (2008) 1.66
Mouse p56 blocks a distinct function of eukaryotic initiation factor 3 in translation initiation. J Biol Chem (2004) 1.63
Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J Virol (2003) 1.62
2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog (2012) 1.62
Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene (2003) 1.59
Novel characteristics of the function and induction of murine p56 family proteins. J Virol (2008) 1.52
Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein. J Virol (2002) 1.52
Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology (2006) 1.47
Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol (2010) 1.45
Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1. J Biol Chem (2008) 1.45
The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. J Virol (2004) 1.43
Induction and mode of action of the viral stress-inducible murine proteins, P56 and P54. Virology (2005) 1.40
Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers. J Virol (2012) 1.37
Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31. J Virol (2004) 1.35
Desmoplakin assembly dynamics in four dimensions: multiple phases differentially regulated by intermediate filaments and actin. J Cell Biol (2005) 1.35
Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J Virol (2011) 1.33
Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification. Proc Natl Acad Sci U S A (2007) 1.33
Acute management of propionic acidemia. Mol Genet Metab (2011) 1.30
Double-stranded RNA signaling by Toll-like receptor 3 requires specific tyrosine residues in its cytoplasmic domain. J Biol Chem (2002) 1.29
Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice. J Virol (2007) 1.28
Molecular basis for PKR activation by PACT or dsRNA. Proc Natl Acad Sci U S A (2006) 1.28
Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication. J Virol (2006) 1.27
A role of the double-stranded RNA-binding protein PACT in mouse ear development and hearing. Proc Natl Acad Sci U S A (2006) 1.26
Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression. J Virol (2002) 1.23
Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res (2010) 1.23
HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs. EMBO J (2005) 1.21
Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses. Virology (2009) 1.18
The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes. J Biol Chem (2005) 1.17
Differentiation of HPV-containing cells using organotypic "raft" culture or methylcellulose. Methods Mol Med (2005) 1.17
Role of the E1--E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. J Virol (2005) 1.16
Human papillomaviruses target the double-stranded RNA protein kinase pathway. J Gen Virol (2006) 1.16
The IRF-3/Bax-mediated apoptotic pathway, activated by viral cytoplasmic RNA and DNA, inhibits virus replication. J Virol (2011) 1.13
Epidermal growth factor receptor is essential for Toll-like receptor 3 signaling. Sci Signal (2012) 1.12
Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11. J Virol (2004) 1.11
Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding. Virology (2008) 1.10
The interferon (IFN)-induced GTPase, mGBP-2. Role in IFN-gamma-induced murine fibroblast proliferation. J Biol Chem (2001) 1.09
Human papillomaviruses modulate microRNA 145 expression to directly control genome amplification. J Virol (2013) 1.09
Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry. Virol J (2007) 1.08
Phosphorylation of specific serine residues in the PKR activation domain of PACT is essential for its ability to mediate apoptosis. J Biol Chem (2006) 1.07
Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification. J Virol (2005) 1.06
The role of human papillomaviruses in oncogenesis. Recent Results Cancer Res (2014) 1.06
Inhibition of RNase L and RNA-dependent protein kinase (PKR) by sunitinib impairs antiviral innate immunity. J Biol Chem (2011) 1.05
Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes. J Virol (2007) 1.04
Human papillomavirus type 31 life cycle: methods for study using tissue culture models. Methods Mol Biol (2005) 1.03
Two tyrosine residues of Toll-like receptor 3 trigger different steps of NF-kappa B activation. J Biol Chem (2006) 1.02
High-throughput screening for TLR3-IFN regulatory factor 3 signaling pathway modulators identifies several antipsychotic drugs as TLR inhibitors. J Immunol (2010) 1.02
The full-length E1E4 protein of human papillomavirus type 18 modulates differentiation-dependent viral DNA amplification and late gene expression. Virology (2007) 1.01
The fanconi anemia pathway limits human papillomavirus replication. J Virol (2012) 1.01
Phosphatidylinositol 3-kinase signaling delays sendai virus-induced apoptosis by preventing XIAP degradation. J Virol (2011) 1.00
A role for Ifit2 in restricting West Nile virus infection in the brain. J Virol (2013) 1.00
Bap31 is a novel target of the human papillomavirus E5 protein. J Virol (2008) 1.00
Viral degradasome hijacks mitochondria to suppress innate immunity. Cell Res (2013) 0.99
Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance. J Virol (2011) 0.99
Nuclear export of human papillomavirus type 31 E1 is regulated by Cdk2 phosphorylation and required for viral genome maintenance. J Virol (2010) 0.98
The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication. J Virol (2010) 0.98
Role of interferon regulatory factor 3-mediated apoptosis in the establishment and maintenance of persistent infection by Sendai virus. J Virol (2012) 0.98
p63 is necessary for the activation of human papillomavirus late viral functions upon epithelial differentiation. J Virol (2011) 0.96
IRF-3 and Bax: a deadly affair. Cell Cycle (2010) 0.95
The JAK-STAT transcriptional regulator, STAT-5, activates the ATM DNA damage pathway to induce HPV 31 genome amplification upon epithelial differentiation. PLoS Pathog (2013) 0.95
Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation. J Virol (2007) 0.95
Maintenance of normal blood pressure and renal functions are independent effects of angiotensin-converting enzyme. J Biol Chem (2003) 0.94
Hitching RIG to action. Nat Immunol (2005) 0.91
Calmodulin binds to the cytoplasmic domain of angiotensin-converting enzyme and regulates its phosphorylation and cleavage secretion. J Biol Chem (2005) 0.91
An interaction between human papillomavirus 16 E2 and TopBP1 is required for optimum viral DNA replication and episomal genome establishment. J Virol (2012) 0.91
dsRNA-activation of TLR3 and RLR signaling: gene induction-dependent and independent effects. J Interferon Cytokine Res (2014) 0.91
The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle. J Virol (2011) 0.90
Viral evasion of the interferon system. J Interferon Cytokine Res (2009) 0.90
Caspase-8-mediated cleavage inhibits IRF-3 protein by facilitating its proteasome-mediated degradation. J Biol Chem (2011) 0.89
The double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation. Proc Natl Acad Sci U S A (2009) 0.88
Ifit2 deficiency results in uncontrolled neurotropic coronavirus replication and enhanced encephalitis via impaired alpha/beta interferon induction in macrophages. J Virol (2013) 0.88
Regulation of the life cycle of HPVs by differentiation and the DNA damage response. Future Microbiol (2013) 0.87